Atria Investments Inc Grows Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Atria Investments Inc lifted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.6% during the third quarter, HoldingsChannel.com reports. The fund owned 80,131 shares of the company’s stock after buying an additional 1,256 shares during the quarter. Atria Investments Inc’s holdings in Corteva were worth $4,711,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of CTVA. Essex Savings Bank purchased a new stake in Corteva in the third quarter worth about $217,000. Bridges Investment Management Inc. lifted its position in shares of Corteva by 5.8% in the 3rd quarter. Bridges Investment Management Inc. now owns 4,949 shares of the company’s stock worth $291,000 after purchasing an additional 272 shares during the period. Klingman & Associates LLC bought a new position in shares of Corteva during the third quarter valued at approximately $239,000. Rovin Capital UT ADV raised its stake in Corteva by 1.3% in the third quarter. Rovin Capital UT ADV now owns 12,822 shares of the company’s stock worth $754,000 after buying an additional 168 shares in the last quarter. Finally, SpiderRock Advisors LLC lifted its holdings in Corteva by 1.9% during the third quarter. SpiderRock Advisors LLC now owns 37,146 shares of the company’s stock worth $2,184,000 after buying an additional 687 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $57.13 on Wednesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 1.17. The firm’s 50 day simple moving average is $58.22 and its 200-day simple moving average is $55.62. Corteva, Inc. has a 12 month low of $43.22 and a 12 month high of $63.75. The stock has a market capitalization of $39.55 billion, a price-to-earnings ratio of 57.71, a PEG ratio of 1.72 and a beta of 0.77.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be issued a $0.17 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 1.19%. Corteva’s payout ratio is 68.69%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Oppenheimer reiterated an “outperform” rating and issued a $70.00 price target (up from $69.00) on shares of Corteva in a report on Friday, November 8th. Bank of America upgraded shares of Corteva from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $59.00 to $67.00 in a report on Wednesday, October 16th. UBS Group raised their price target on shares of Corteva from $67.00 to $71.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Argus lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, Wells Fargo & Company lowered their target price on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a research note on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $63.68.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.